James A Geraghty - Net Worth and Insider Trading
James A Geraghty Net Worth
The estimated net worth of James A Geraghty is at least $2 Million dollars as of 2024-11-13. James A Geraghty is the Director of Juniper Pharmaceuticals Inc and owns about 65,153 shares of Juniper Pharmaceuticals Inc (JNP) stock worth over $749,260. James A Geraghty is the Director of Voyager Therapeutics Inc and owns about 76,588 shares of Voyager Therapeutics Inc (VYGR) stock worth over $523,096. James A Geraghty is also the Director of Fulcrum Therapeutics Inc and owns about 90,714 shares of Fulcrum Therapeutics Inc (FULC) stock worth over $331,106. Besides these, James A Geraghty also holds Pieris Pharmaceuticals Inc (PIRS) , Aceragen Inc (ACGN) . Details can be seen in James A Geraghty's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James A Geraghty has not made any transactions after 2021-06-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of James A Geraghty
James A Geraghty Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James A Geraghty owns 6 companies in total, including Aceragen Inc (ACGN) , Pieris Pharmaceuticals Inc (PIRS) , and Orchard Therapeutics PLC (ORTX) among others .
Click here to see the complete history of James A Geraghty’s form 4 insider trades.
Insider Ownership Summary of James A Geraghty
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ACGN | Aceragen Inc | 2018-08-07 | director |
| PIRS | Pieris Pharmaceuticals Inc | 2018-05-15 | director |
| ORTX | Orchard Therapeutics PLC | 2020-01-01 | director |
 | | 2021-06-28 | director |
| | 2018-09-10 | director |
| | 2018-08-14 | director |
James A Geraghty Latest Holdings Summary
James A Geraghty currently owns a total of 5 stocks. Among these stocks, James A Geraghty owns 65,153 shares of Juniper Pharmaceuticals Inc (JNP) as of March 17, 2017, with a value of $749,260 and a weighting of 46.57%. James A Geraghty owns 76,588 shares of Voyager Therapeutics Inc (VYGR) as of September 10, 2018, with a value of $523,096 and a weighting of 32.51%. James A Geraghty also owns 90,714 shares of Fulcrum Therapeutics Inc (FULC) as of June 28, 2021, with a value of $331,106 and a weighting of 20.58%. The other 2 stocks Pieris Pharmaceuticals Inc (PIRS) , Aceragen Inc (ACGN) have a combined weighting of 0.34% among all his current holdings.
Latest Holdings of James A Geraghty
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| JNP | Juniper Pharmaceuticals Inc | 2017-03-17 | 65,153 | 11.50 | 749,260 |
| VYGR | Voyager Therapeutics Inc | 2018-09-10 | 76,588 | 6.83 | 523,096 |
| FULC | Fulcrum Therapeutics Inc | 2021-06-28 | 90,714 | 3.65 | 331,106 |
| PIRS | Pieris Pharmaceuticals Inc | 2018-05-15 | 250 | 16.12 | 4,030 |
| ACGN | Aceragen Inc | 2018-08-07 | 3,849 | 0.38 | 1,463 |
Holding Weightings of James A Geraghty
James A Geraghty Form 4 Trading Tracker
According to the SEC Form 4 filings, James A Geraghty has made a total of 0 transactions in Juniper Pharmaceuticals Inc (JNP) over the past 5 years. The most-recent trade in Juniper Pharmaceuticals Inc is the acquisition of 2,000 shares on March 17, 2017, which cost James A Geraghty around $9,640.
According to the SEC Form 4 filings, James A Geraghty has made a total of 0 transactions in Voyager Therapeutics Inc (VYGR) over the past 5 years. The most-recent trade in Voyager Therapeutics Inc is the acquisition of 3,000 shares on September 10, 2018, which cost James A Geraghty around $58,170.
According to the SEC Form 4 filings, James A Geraghty has made a total of 1 transactions in Fulcrum Therapeutics Inc (FULC) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Fulcrum Therapeutics Inc is the acquisition of 10,000 shares on June 28, 2021, which cost James A Geraghty around $91,600.
More details on James A Geraghty's insider transactions can be found in the Insider Trading History of James A Geraghty table.Insider Trading History of James A Geraghty
- 1
James A Geraghty Trading Performance
GuruFocus tracks the stock performance after each of James A Geraghty's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James A Geraghty is 29.21%. GuruFocus also compares James A Geraghty's trading performance to market benchmark return within the same time period. The performance of stocks bought by James A Geraghty within 3 months outperforms 10 times out of 16 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how James A Geraghty's insider trading performs compared to the benchmark.
Performance of James A Geraghty
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 15.24 | | | | | |
| Relative Return to S&P 500(%) | 14.75 | | | | | |
James A Geraghty Ownership Network
Ownership Network List of James A Geraghty
Ownership Network Relation of James A Geraghty
James A Geraghty Owned Company Details
What does Aceragen Inc do?
Who are the key executives at Aceragen Inc?
James A Geraghty is the director of Aceragen Inc. Other key executives at Aceragen Inc include director & President & CEO Vincent Milano , director & 10 percent owner Pillar Invest Corp , and 10 percent owner Atul Chopra .
Aceragen Inc (ACGN) Insider Trades Summary
Over the past 18 months, James A Geraghty made no insider transaction in Aceragen Inc (ACGN). Other recent insider transactions involving Aceragen Inc (ACGN) include a net purchase of 21,147 shares made by Pillar Invest Corp , a net sale of 135,672 shares made by Atul Chopra , and a net sale of 3,283 shares made by Vincent Milano .
In summary, during the past 3 months, insiders sold 0 shares of Aceragen Inc (ACGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 144,824 shares of Aceragen Inc (ACGN) were sold and 26,965 shares were bought by its insiders, resulting in a net sale of 117,859 shares.
Aceragen Inc (ACGN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aceragen Inc Insider Transactions
James A Geraghty Mailing Address
Above is the net worth, insider trading, and ownership report for James A Geraghty. You might contact James A Geraghty via mailing address: C/o Idera Pharmaceuticals, Inc., 167 Sidney Street, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
